<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-N69HFACJ</identifier><date>2022</date><creator>Andlovic, Aljoša</creator><creator>Novak, Nadja</creator><creator>Roš Opaškar, Rok</creator><relation>documents/doc/N/URN_NBN_SI_doc-N69HFACJ_001.pdf</relation><relation>documents/doc/N/URN_NBN_SI_doc-N69HFACJ_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 83-86</format><identifier identifier_type="COBISSID_HOST">137979139</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-N69HFACJ</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Dnevi internistične onkologije 2022</source><rights>InC</rights><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">sistemsko zdravljenje</subject><title>Neurological adverse events of immune checkpoint inhibitors</title><title>Nevrološki zapleti zdravljenja z zaviralci imunskih nadzornih točk</title></Record>